Slingshot members are tracking this event:

Lilly's (LLY) Lartruvo Approved by FDA by Soft Tissue Sarcoma

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 19, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Lartruvo, Soft Tissue Sarcoma, Fda, Phase 2, Jgdg, Doxorubicin